Rare diseases
Investigational molecules
Locations
Study Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
BelgiumStudy of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma
CzechiaStudy of Nivolumab and Relatlimab for Patients with Resectable Non-Small Cell Lung Cancer
BelgiumStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
AustriaStudy Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
BelgiumStudy on the Effects of DFV890 for Pain Relief in Patients with Knee Osteoarthritis
CzechiaStudy Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients
BelgiumStudy on Low Dose Rivaroxaban for Heart and Blood Vessel Disease in Patients with Advanced Kidney Disease or on Dialysis
BelgiumStudy of Entrectinib in Children and Adolescents with Advanced or Metastatic Solid Tumors or Primary CNS Tumors with No Satisfactory Treatment Options
FranceStudy Comparing Ipilimumab and Nivolumab with Standard Nivolumab for Patients with Stage III Melanoma
FranceStudy on Zoledronic Acid for Patients with Hip Fractures: Evaluating Early Treatment Safety and Effectiveness
NorwayStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
